PH12013500583A1 - Cyclohexane derivative compound - Google Patents

Cyclohexane derivative compound

Info

Publication number
PH12013500583A1
PH12013500583A1 PH1/2013/500583A PH12013500583A PH12013500583A1 PH 12013500583 A1 PH12013500583 A1 PH 12013500583A1 PH 12013500583 A PH12013500583 A PH 12013500583A PH 12013500583 A1 PH12013500583 A1 PH 12013500583A1
Authority
PH
Philippines
Prior art keywords
group
optionally substituted
alkyl group
hydrogen atom
alkyl
Prior art date
Application number
PH1/2013/500583A
Other languages
English (en)
Inventor
Yamazaki Mami
Iwamoto Mitsuhiro
Toda Narihiro
Takano Rieko
Ashida Shinji
Katagiri Takahiro
Shida Takeshi
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of PH12013500583A1 publication Critical patent/PH12013500583A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255Tartaric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • C07D213/6432-Phenoxypyridines; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH1/2013/500583A 2010-09-27 2011-09-26 Cyclohexane derivative compound PH12013500583A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010215403 2010-09-27
PCT/JP2011/071830 WO2012043445A1 (ja) 2010-09-27 2011-09-26 シクロヘキサン誘導体化合物

Publications (1)

Publication Number Publication Date
PH12013500583A1 true PH12013500583A1 (en) 2013-05-20

Family

ID=45892891

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/500583A PH12013500583A1 (en) 2010-09-27 2011-09-26 Cyclohexane derivative compound

Country Status (29)

Country Link
US (3) US8710060B2 (OSRAM)
EP (1) EP2623492B1 (OSRAM)
JP (1) JP5753179B2 (OSRAM)
KR (1) KR20130109124A (OSRAM)
CN (1) CN103108866B (OSRAM)
AU (1) AU2011309212B2 (OSRAM)
BR (1) BR112013007145A2 (OSRAM)
CA (1) CA2812898C (OSRAM)
CO (1) CO6690804A2 (OSRAM)
CY (1) CY1115450T1 (OSRAM)
DK (1) DK2623492T3 (OSRAM)
ES (1) ES2478518T3 (OSRAM)
HR (1) HRP20140720T1 (OSRAM)
IL (1) IL225440A (OSRAM)
IN (1) IN2013MN00506A (OSRAM)
MX (1) MX2013003219A (OSRAM)
MY (1) MY157542A (OSRAM)
NZ (1) NZ609596A (OSRAM)
PH (1) PH12013500583A1 (OSRAM)
PL (1) PL2623492T3 (OSRAM)
PT (1) PT2623492E (OSRAM)
RS (1) RS53447B (OSRAM)
RU (1) RU2013119603A (OSRAM)
SG (1) SG188415A1 (OSRAM)
SI (1) SI2623492T1 (OSRAM)
SM (1) SMT201400109B (OSRAM)
TW (1) TWI501953B (OSRAM)
WO (1) WO2012043445A1 (OSRAM)
ZA (1) ZA201301652B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ609596A (en) * 2010-09-27 2013-12-20 Daiichi Sankyo Co Ltd Cyclohexane derivative compound
US10352962B2 (en) 2016-12-29 2019-07-16 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis and feedback
US11318350B2 (en) 2016-12-29 2022-05-03 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis, and feedback
US10973439B2 (en) 2016-12-29 2021-04-13 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis, and feedback
US9773330B1 (en) 2016-12-29 2017-09-26 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis, and feedback

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511980B2 (en) * 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists
US7262195B2 (en) 2003-09-17 2007-08-28 Bristol-Myers Squibb Company Compounds useful as motilin agonists and method
GB0611907D0 (en) 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
GB0515381D0 (en) * 2005-07-26 2005-08-31 Glaxo Group Ltd Compounds
GB0612844D0 (en) * 2006-06-28 2006-08-09 Glaxo Group Ltd Compounds
US7700599B2 (en) * 2006-06-28 2010-04-20 Glaxo Group Limited Gpr38 Receptor Agonists
GB0723317D0 (en) 2007-11-28 2008-01-09 Glaxo Group Ltd Compounds
NZ609596A (en) * 2010-09-27 2013-12-20 Daiichi Sankyo Co Ltd Cyclohexane derivative compound

Also Published As

Publication number Publication date
PT2623492E (pt) 2014-08-29
EP2623492A4 (en) 2013-09-25
CO6690804A2 (es) 2013-06-17
SMT201400109B (it) 2014-09-08
MX2013003219A (es) 2013-06-18
TWI501953B (zh) 2015-10-01
EP2623492A1 (en) 2013-08-07
IN2013MN00506A (OSRAM) 2015-05-29
US20140221392A1 (en) 2014-08-07
US8710060B2 (en) 2014-04-29
JP5753179B2 (ja) 2015-07-22
EP2623492B1 (en) 2014-05-14
CY1115450T1 (el) 2017-01-04
ES2478518T3 (es) 2014-07-22
HRP20140720T1 (hr) 2014-08-29
CA2812898C (en) 2015-11-17
SG188415A1 (en) 2013-04-30
TW201217342A (en) 2012-05-01
CN103108866B (zh) 2015-09-09
AU2011309212A1 (en) 2013-03-21
CA2812898A1 (en) 2012-04-05
RU2013119603A (ru) 2014-11-10
PL2623492T3 (pl) 2014-09-30
ZA201301652B (en) 2014-04-30
RS53447B (en) 2014-12-31
WO2012043445A1 (ja) 2012-04-05
IL225440A0 (en) 2013-06-27
US9051255B2 (en) 2015-06-09
AU2011309212B2 (en) 2014-06-19
MY157542A (en) 2016-06-15
KR20130109124A (ko) 2013-10-07
CN103108866A (zh) 2013-05-15
IL225440A (en) 2015-11-30
DK2623492T3 (da) 2014-08-11
BR112013007145A2 (pt) 2016-06-14
SI2623492T1 (sl) 2014-09-30
JPWO2012043445A1 (ja) 2014-02-06
US20130289048A1 (en) 2013-10-31
US20140221391A1 (en) 2014-08-07
NZ609596A (en) 2013-12-20
HK1185081A1 (en) 2014-02-07

Similar Documents

Publication Publication Date Title
PH12014500434A1 (en) New dihydroquinoline-2-one derivatives
AR088226A1 (es) Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas
CO6341631A2 (es) Derivados de 1,2,4 - oxadiazol y su uso terapéutico
PH12012501546A1 (en) Substituted pyrrolidine-2-carboxamides
AR072227A1 (es) Derivados de triazinona sustituidos
IL208636A0 (en) Spirocyclic derivatives as histone deacetylase inhibitors
CU24030B1 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
MX2013005833A (es) Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa.
MX2012002528A (es) Agente terapeutico para trastornos del estado de animo.
UA105786C2 (uk) Адитивні солі амінів, що містять гідроксильні і/або карбоксильні групи, з похідними амінонікотинової кислоти як інгібітори dhodh
MY178760A (en) Monocyclic pyridine derivative
MX2011013884A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas.
PH12013500583A1 (en) Cyclohexane derivative compound
MX343225B (es) Nuevos derivados de aril-benzocicloalquil-amida.
PH12015502429A1 (en) Dicarboxylic acid compound
MX2011011303A (es) Derivados de isoxazol.
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
MY150774A (en) Isoquinoline derivative
PH12016500152A1 (en) Novel triazine derivative
EA201000398A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
MY178583A (en) Hydantoin derivative
EA201200498A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
MX2013010962A (es) Nuevos derivados de furanona.
EA200700360A1 (ru) Новые производные амида гетероциклической карбоновой кислоты
TN2012000093A1 (en) Therapeutic agent for anxiety disorders